"Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

The patterns of dupilumab use, the first systemic drug approved for the treatment of atopic dermatitis (AD), is not well understood in the context of off‐label systemic medications. Click to show full abstract

The patterns of dupilumab use, the first systemic drug approved for the treatment of atopic dermatitis (AD), is not well understood in the context of off‐label systemic medications.

Keywords: systemic immunomodulators; use patterns; patterns systemic; atopic dermatitis; use

Journal Title: Pharmacoepidemiology and Drug Safety
Year Published: 2022

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended